MDMA: On the translation from rodent to human dosing

Psychopharmacology

Volumn 204, Issue 2, 2009, Pages 375-378

  Green, A Richard ^a   Gabrielsson, Johan ^b   Marsden, Charles A ^a   Fone, Kevin C F ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

AREA UNDER THE CURVE; DRUG BIOAVAILABILITY; DRUG EXPOSURE; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG RESPONSE; HUMAN; MAXIMUM PLASMA CONCENTRATION; MEDICAL LITERATURE; METABOLITE; NEUROTOXICITY; NONHUMAN; NOTE; PHARMACODYNAMICS; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL; UNSPECIFIED SIDE EFFECT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HALLUCINOGENS; HUMANS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; SPECIES SPECIFICITY;

EID: 67349283799     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-008-1453-8     Document Type: Note

References (30)

1. T Chu Y Kumagai EW DiStefano AK Cho 1996 Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion Biochem Pharmacol 51 789 796 (Pubitemid 26094447)
2. MI Colado JL Williams AR Green 1995 The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype Br J Pharmacol 115 1281 1289
3. R de la Torre M Farré 2004 Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans Trends Pharmacol Sci 25 505 508 (Pubitemid 39233561)
4. R de la Torre M Farré J Ortuno M Mas R Brenneisen PN Roset J Segura J Cami 2000 Non-linear pharmacokinetics of MDMA ('ecstasy') in humans Br J Clin Pharmacol 49 104 109 (Pubitemid 30068287)
5. R de la Torre M Farré PN Roset N Pizarro S Abanandes M Segura J Segura J Cami 2004 Human pharmacology of MDMA, pharmacokinetics, metabolism and disposition Ther Drug Monit 26 137 144 (Pubitemid 38501207)
6. N Easton CA Marsden 2006 Ecstasy: are animal data consistent between species and can they translate to humans? J Psychopharmacol 20 194 210
7. E Esteban E O'Shea J Camarero V Sanchez AR Green MI Colado 2001 3,4-methylenedioxymethamphetamine induces monoamine release but not toxicity when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose Psychopharmacology 154 251 260 (Pubitemid 32247186)
8. M Farré S Abanades PN Roset AM Peiro M Torrens B O'Mathuna M Segura R de la Torre 2007 Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics J Pharmacol Exp Ther 323 954 962 (Pubitemid 350146071)
9. ER Garrett K Seyda P Marroum 1991 High performance liquid chromatography assays of the illicit designer drug "ecstasy", a modified amphetamine, with applications to stability, partitioning and plasma protein binding Acta Pharm Nord 3 9 14
10. B Goni-Allo BÓ Mathúna M Segura E Puerta B Lasheras R de la Torre N Aguirre 2008 The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity Psychopharmacology 197 263 278
11. AR Green AO Mechan JM Elliott E O'Shea MI Colado 2003 The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") Pharmacol Revs 55 463 508 (Pubitemid 37013213)
12. AR Green V Sanchez E O'Shea KS Saadat JM Elliott MI Colado 2004 Effect of ambient temperature and a prior neurotoxic dose of 3, 4- methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA Psychopharmacology 173 264 269 (Pubitemid 38703799)
13. AR Green CA Marsden KCF Fone 2008 MDMA as a clinical tool: a note of caution. A response to Sessa and Nutt J Psychopharmacol 22 929 931
14. SL Greene PI Dargan N O'Connor AL Jones M Kerins 2003 Multiple toxicity from 3,4-methylenedioxymethamphetamine ("ecstasy") Am J Emerg Med 21 121 124 (Pubitemid 36396822)
15. C Hernandez-Lopez M Farré PN Roset E Menoyo N Pizarro J Ortuno M Torrens J Cami R de La Torre 2002 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics J Pharmacol Exp Ther 300 236 244 (Pubitemid 34028533)
16. M Hiramatsu E DiStefano AS Chang AK Cho 1991 A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates Eur J Pharmacol 204 135 140
17. RS Kolbrich EA Goodwin DA Gorelick RJ Hayes EA Stein MA Huestis 2008 Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults Ther Drug Monit 30 320 332
18. M Mas M Farré R de la Torre PN Roset J Ortuno J Segura J Cami 1999 Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans J Pharmacol Exp Ther 290 136 145 (Pubitemid 29302313)
19. BÓ Mathúna M Farré A Rastami-Hodjegan J Yang E Cuyas M Torrens R Pardo S Abanades S Maluf GT Tucker R de la Torre 2008 The consequences of 3,4-methylenedioxymethamphetamine induced CYP 2D6 inhibition in humans J Clin Psychopharmacol 28 523 531
20. UD McCann GA Ricaurte 2001 Caveat emptor: editors beware Neuropsychopharmacology 24 333 336 (Pubitemid 32157562)
21. Mordenti J, Chappell W (1989) The use of interspecies scaling in toxicokinetics. In: Yacogi A, Kelly J, Batra V (eds) Toxicokinetics and new drug development. Pergamon, New York, pp 42-96
22. S Morley-Fletcher M Puopolo S Gentili G Gerara T Macchia G Laviola 2004 Prenatal stress affects 3,4-methylenedioxymethamphetamine pharmacokinetics and drug induced motor alterations in adolescent female rats Eur J Pharmacol 489 89 92 (Pubitemid 38520075)
23. E O'Shea B Esteban J Camarero AR Green MI Colado 2001 Effect of GBR12909 and fluoxetine on the acute and long term changes induced by MDMA ("ecstasy") on the 5-HT and dopamine concentrations in mouse brain Neuropharmacology 40 65 71 (Pubitemid 33779801)
24. GA Ricaurte J Yuan G Hatzidimitriou BJ Cord UD McCann 2002 Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy") Science 297 2260 2263
25. GA Ricaurte J Yuan G Hatzidimitriou BJ Cord UD McCann 2003 Retraction Science 301 1479
26. B Sessa DJ Nutt 2007 MDMA, politics and medical research: have we thrown out the baby with the bathwater? J Psychopharmacol 21 787 791 (Pubitemid 350029179)
27. B Sessa DJ Nutt 2008 Reply to letter by Green Marsden and Fone (2007) about Sessa and Nutt's editorial (MDMA: baby with the bathwater) J Psychopharmacol 22 457 458
28. VV Upreti ND Eddington 2007 Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) in rat J Pharmaceut Sci 97 1593 1605
29. S Valtier CF Phelix JT Cody 2007 Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA J Analyt Toxicol 31 138 143 (Pubitemid 46641584)
30. J Yang M Jamei A Heydari KR Yeo R de la Torre M Farré GT Tucker A Rostami-Hodjegan 2006 Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA J Psychopharmacol 20 842 849 (Pubitemid 44622750)